Girls Aloud band members Cheryl, Kimberley Walsh, Nadine Coyle, and Nicola Roberts shared a significant update this week regarding the Sarah Harding Breast Cancer Appeal.
In a joint statement, the group announced that The Christie NHS Foundation Trust in Manchester has appointed a new full-time researcher, Dr. Hannah Harrison.
This appointment marks a major milestone in their ongoing mission to fund vital research into breast cancer in young women.
Sarah Harding passed away at the age of 39 in September 2021 following a battle with advanced breast cancer.
Before her death, she expressed a deep desire to help other young women avoid the "shock and devastation" of a late diagnosis.
The band promised to fulfill this wish, and they have worked tirelessly since her passing to raise money for the cause.
The hire of Dr. Harrison will spearhead an ambitious program focused on innovative prevention strategies for women in their 30s.
After all, the appeal supports a groundbreaking project known as BCAN-RAY (Breast Cancer Risk Assessment in Young Women).
Furthermore this study explores risk factors for women between the ages of 30 and 39 who do not have a family history of the disease.
Recent reports indicate that the research has already made a real-world impact by identifying more than 85 young women who face an increased risk of developing cancer.
These women can now access early screening and personalized care.
In their statement, the band members described the progress as "hugely significant."
They noted that Sarah believed in the power of progress and would be thrilled to see a dedicated researcher focusing on this work.
The group continues to use their platform to encourage fans to support the appeal and remain proactive about their health.
This latest update proves that Sarah’s legacy continues to protect and help future generations of women.